I kind of feel the shareholder vote is a very separate procedure than what is going on with financing and trial developments. They can’t coordinate conference presentations with trial events and the items we are voting on are very administrative. My impression is that the increase in share count is just house keeping that requires a shareholder vote, that is all. The “plan” Nader is going to reveal at some point is confusing, is it some path they intend to pursue or do they actually have a partnership to license deal? Why are we constantly in the dark about the finances?